osimertinib
astrazeneca
['adaura', 'lcsm,(-blcsm)', 'osimertinib', 'aura ,(-laura)']
the next big thing in adaura is how to adequately treat patients to had pd during osimertinib. this is a major challenge in the clinic. especially for patients not amenable to local therapy. it is fundamental to understand mechanisms of resistance in this setting. #asco23 #lcsm
Husband, Father.
Medical Oncologist and Researcher focused in Thoracic Oncology.
Views are my own.